Preparing for RSV: New prevention drug and 2023 forecast
Every fall, pediatricians begin to brace for seasonal viruses that will start making their way through younger populations, including respiratory syncytial virus (RSV). A new FDA-approved RSV preventative drug called Beyfortus (nirsevimab-alip) could be a game-changer in the fight against RSV during the upcoming fall and winter.